|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Less: income (loss) from discontinued operations, net of tax | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Gain on discontinued operations, net of taxes | |||||
| Realized loss on marketable debt securities | |||||
| Depreciation and amortization | |||||
| Amortization of debt discount | |||||
| Impairment loss | |||||
| Amortization on right-of-use assets | |||||
| Consulting expense paid through reduction of secured promissory note receivable | |||||
| Gain from disposal of fixed assets | |||||
| Loss from investment in unconsolidated affiliates | |||||
| Loss on issuance of debt | |||||
| Loss from lease termination | |||||
| Loss (gain) from disposal of fixed assets | |||||
| Employee retention tax credit income | |||||
| Stock-based compensation expense | |||||
| Change in fair value of investment securities | |||||
| Accounts receivable allowances | |||||
| Inventory valuation reserve | |||||
| Credit loss expense, direct write-offs | |||||
| Inventory write-offs | |||||
| Change in fair value of warrant liability | |||||
| Change in fair value of derivative liability | |||||
| Debt extinguishment (gain) loss | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Deferred tax asset | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Accrued diagnostic services | |||||
| Accrued advertising and other allowances | |||||
| Deferred revenue | |||||
| Deferred tax liability | |||||
| Lease liabilities | |||||
| Income taxes payable | |||||
| Other liabilities | |||||
| Net cash used in operating activities - continuing operations | |||||
| Net cash provided by (used in) operating activities - discontinued operations | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Business acquisitions, escrow received | |||||
| Business acquisitions, net of cash acquired | |||||
| Issuance of secured promissory note receivable | |||||
| Purchase of marketable securities | |||||
| Proceeds from sales of marketable securities | |||||
| Proceeds from maturities of marketable securities | |||||
| Proceeds from promissory note | |||||
| Proceeds from dispositions of property and other assets, net | |||||
| Capital expenditures | |||||
| Net cash provided by investing activities - continuing operations | |||||
| Net cash provided by (used in) investing activities - discontinued operations | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of common stock from public offering, net | |||||
| Proceeds from issuance of note payable | |||||
| Proceeds from exercise of warrants | |||||
| Repayment of common stock for payment of statutory taxes on cashless exercise of stock options | |||||
| Proceeds from issuance of note payable to related party | |||||
| Proceeds from issuance of convertible notes payable | |||||
| Proceeds from issuance of common shares, net | |||||
| Repayment of note payable | |||||
| Repurchases of common shares | |||||
| Payment of dividends | |||||
| Repayment of convertible notes payable | |||||
| Net cash provided by financing activities - continuing operations | |||||
| Net cash (used in) provided by financing activities - discontinued operations | |||||
| Net cash provided by financing activities | |||||
| Decrease in cash, cash equivalents and restricted cash | |||||
| Cash and cash equivalents at the beginning of the year | |||||
| Cash and cash equivalents at the end of the year | |||||
| Supplemental disclosures: | |||||
| Cash paid for income taxes | |||||
| Interest payment on the promissory notes | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Assets obtained in exchange for new finance lease obligations | |||||
| Issuance of treasury shares as collateral for a loan | |||||
| Stock-based compensation included in the prepaid expense | |||||
| Issuance of common shares for debt conversion | |||||
| Net unrealized loss, investments in marketable debt securities | |||||
| Issuance of common shares as collateral for a loan | |||||
| Issuance of common stock as commitment fee for future financing | |||||
| Issuance of common stock to convert outstanding convertible notes and interest | |||||
| Issuance of liability classified warrants associated with notes payable | |||||
| Net unrealized loss, investments in marketable securities | |||||
| Issuance of warrants with unsecured promissory note | |||||
| Common stock issued in asset acquisition | |||||
| Deconsolidation of subsidiaries assets and liabilities | |||||
| Recognition investment in nonconsolidated subsidiaries | |||||
Loading...